Evaluation and Management of Low RBC, Hemoglobin, and Hematocrit
Begin with a complete blood count (CBC) with differential, reticulocyte count, and iron studies (serum ferritin and transferrin saturation) to determine the type and cause of anemia, then proceed with targeted investigation based on red cell indices and clinical context.
Initial Diagnostic Approach
The evaluation must be systematic and algorithmic. Hemoglobin is the preferred measure over hematocrit because it has better reproducibility across laboratories and is not affected by sample storage time or patient variables like serum glucose 1.
Define the Anemia
First, confirm anemia using gender-specific thresholds 1, 2:
- Males ≥18 years: Hemoglobin <135 g/L (13.5 g/dL)
- Females ≥18 years: Hemoglobin <120 g/L (12.0 g/dL)
- Pregnant women (2nd/3rd trimester): Hemoglobin <110 g/L (11.0 g/dL)
Important caveats: These thresholds may not apply to patients who are pregnant/menstruating, living at high altitude, smokers, age ≥70 years in men, non-Caucasian race, chronic lung disease, or hemoglobinopathies 1.
Essential Initial Laboratory Tests
Step 1: Complete Blood Count with Differential
Order a CBC that includes white blood cells, hemoglobin, platelets, MCV, and MCH 1. This assesses bone marrow function across all cell lines.
Critical decision point: If abnormalities exist in two or more cell lines (pancytopenia), this warrants immediate hematology consultation as it suggests bone marrow failure or infiltrative process 1.
Step 2: Classify by Red Cell Indices
Mean Corpuscular Volume (MCV) guides the differential diagnosis 1:
- Low MCV (microcytic): Suggests iron deficiency, thalassemia, or inherited hemoglobin synthesis disorders
- Normal MCV (normocytic): Suggests chronic disease, chronic kidney disease, or early nutritional deficiency
- High MCV (macrocytic): Suggests B12/folate deficiency or myelodysplastic syndrome
Mean Corpuscular Hemoglobin (MCH) is more reliable than MCV as it's less dependent on storage and counting machines, and shows reduction in both absolute and functional iron deficiency 2.
Step 3: Reticulocyte Count
Order an absolute reticulocyte count or reticulocyte index to assess bone marrow response 1.
- Low reticulocyte count: Indicates inadequate bone marrow response—consider iron unavailability, erythropoietin deficiency, or inflammation
- High reticulocyte count: Indicates appropriate marrow response—look for hemolysis or acute blood loss
Step 4: Iron Studies
Serum ferritin is the single most useful marker for iron deficiency 2. Order ferritin and transferrin saturation together 1.
Iron deficiency thresholds:
- Ferritin <15 μg/L: Indicates absent iron stores
- Ferritin <30 μg/L: Generally indicates low body iron stores
- Ferritin <45 μg/L: May indicate iron deficiency in inflammatory states (ferritin is an acute phase reactant) 2
Transferrin saturation represents iron available to bone marrow for erythropoiesis 1.
Targeted Investigation Based on Findings
If Microcytic Anemia with Low Ferritin
This is iron deficiency anemia. In patients without obvious blood loss (menstruation, known GI bleeding), investigate for occult gastrointestinal bleeding 1. Consider:
- Upper and lower endoscopy, especially if hemoglobin <110 g/L in men or <100 g/L in non-menstruating women 2
- Celiac serology (malabsorption)
If Microcytic Anemia with Normal Iron Studies
Order hemoglobin electrophoresis to exclude thalassemia, particularly in appropriate ethnic backgrounds 2. Thalassemia typically shows MCV reduced out of proportion to anemia level.
If Normocytic Anemia
Evaluate for:
- Chronic kidney disease: Check creatinine and estimated GFR—anemia of CKD is typically normochromic and normocytic 1
- Chronic disease/inflammation: Check inflammatory markers (CRP, ESR)
- Early nutritional deficiency: May not yet show MCV changes
If Macrocytic Anemia
Check vitamin B12 and folate levels. Consider bone marrow evaluation if these are normal, as myelodysplastic syndrome becomes more likely 3.
Treatment Principles
Iron Deficiency Anemia
A good response to iron therapy (hemoglobin rise ≥10 g/L within 2 weeks) is highly suggestive of absolute iron deficiency, even if iron studies are equivocal 2. This serves as both diagnostic and therapeutic.
First-line treatment is oral iron, with emerging evidence suggesting intermittent dosing is as effective as daily dosing with fewer side effects 4.
Use intravenous iron for patients who cannot tolerate, cannot absorb, or do not respond to oral iron 5, 4.
Anemia of Chronic Kidney Disease
In CKD patients not on erythropoietic-stimulating agents, screen for anemia at least yearly given the association with increased mortality and progression to end-stage renal disease 1. More frequent monitoring is needed in diabetic patients who develop anemia earlier 1.
Common Pitfalls to Avoid
Don't rely on hematocrit alone—it's less reproducible and affected by storage and patient variables 1
Don't miss functional iron deficiency—ferritin may appear normal in inflammatory states; consider transferrin saturation and clinical context 2
Don't overlook GI malignancy—unexplained iron deficiency in adults without obvious blood loss requires GI investigation 1, 2
Don't forget to check all cell lines—pancytopenia requires different management than isolated anemia 1
Don't assume CKD is the sole cause—patients with CKD may have multiple contributing factors to anemia 1